Guidance for Novelion Therapeutics (NVLN)

Period Range Estimate Revenue Range Revenue Estimate Target Details
Q3 2017 N/A N/A N/A N/A = Maintained Details
Q2 2017 N/A N/A $155.00M – 165.00M N/A = Maintained Details
Q1 2017 N/A N/A N/A N/A = Maintained Details